Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Pavillion Capital

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 7
Rounds per year 0.70
Lead investments 1
Exits 2
Key employees 1
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Financial Services
  • Software
  • Finance
  • B2B
  • Enterprise Software
Summary

In 2012 was created Pavillion Capital, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined VC is situated in the London.

Among the most popular fund investment industries, there are B2B, Procurement. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Ascletis, Tradeshift, Yodo1.

The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2014. This Pavillion Capital works on 9 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018. The average startup value when the investment from Pavillion Capital is 100-500 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The overall number of key employees were 1.

The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Pavillion Capital, startups are often financed by Notion, Lightspeed Venture Partners, Infinity Ventures. The meaningful sponsors for the fund in investment in the same round are Tasly Pharmaceutical, Singtel Innov8, Sequoia Capital. In the next rounds fund is usually obtained by Santander InnoVentures, DCM Ventures, e.ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pavillion Capital:
Typical Co-investors
Pavillion Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pavillion Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3dot6 Ventures -
Alphachain Puerto Rico, San Juan, United States
Cantor Fitzgerald New York, New York, United States
Cavallo Consulting California, Corona, United States
Celanese Irving, Texas, United States
Clal Insurance Enterprises Holdings Israel, Kiryat Gat, South District
DNB Norway, Oslo
Future Positive Capital France, Ile-de-France, Paris
Halyard Capital New York, New York, United States
Hull Street Capital Bethesda, Maryland, United States
Intel California, Santa Clara, United States
LG Uplus Seoul, Seoul-t'ukpyolsi, South Korea
Montage Ventures California, Menlo Park, United States
Mount Nathan Advisors Central, Central Region, Singapore
O.R.Technologies -
Rose-Hulman Ventures Indiana, Terre Haute, United States
SODICAL Castilla y Leon, Spain, Valladolid
Trainocate Japan Japan, Tokyo
Warby Parker New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Circle Pharma

Biotechnology
Clinical Trials
Health Care
Therapeutics
$66M16 Jun 2021 San Francisco, California, United States

Zilliz

Artificial Intelligence
Database
Machine Learning
Open Source
Software
$43M16 Nov 2020 Shanghai, China

Tradeshift

B2B
Enterprise Software
Financial Services
FinTech
Procurement
SaaS
Transaction Processing
$75M09 Jun 2016 San Francisco, California, United States

Ascletis

Health Care
Medical
Therapeutics
$35M02 Sep 2015 North Carolina, United States

freee

Accounting
B2B
Banking
Enterprise Software
Finance
Financial Services
Network Security
Software
$6M25 Sep 2014 Chiyoda, Japan

Credit
Finance
Financial Services
$60M23 Jul 2014 Dongcheng District, Beijing, China

Yodo1

Computer
Gaming
Language Learning
$11M10 Dec 2013 China, Beijing
News
Circle Pharma Raises $66M in Series C Financing

– Circle Pharma from South San Francisco develops macrocycle drug discovery and development company focused on intractable cancer targets.
– The company raised $66m in Series C financing.
– The round was co-led by The Column Group and Nextech Invest with participation from Pandect Bioventures, together with new investors including Euclidean Capital, Pavillion Capital, Hartford HealthCare Endowment and Eli Lilly and Company.
– The new investment will be used to advance its wholly owned cyclin-targeted programs towards the clinic.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pavillion Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: